The Course of Progranulin Levels at Admission and During Early Period of Insulin Treatment in Children with Newly Diagnosed Type 1 Diabetes Mellitus
PDF

Original Article

The Course of Progranulin Levels at Admission and During Early Period of Insulin Treatment in Children with Newly Diagnosed Type 1 Diabetes Mellitus

J Clin Res Pediatr Endocrinol 2026;18(1):123-128 DOI: 10.4274/jcrpe.galenos.2025.2025-3-9
, , , , , ,
PDF
Permissions

Abstract

Objective

Progranulin (PGRN), a growth factor, modulates cell proliferation, wound repair, and inflammation. It is also involved in glucose metabolism and is associated with insulin resistance and diabetes mellitus (DM). In the present study, PGRN levels were measured at admission and during follow-up in children with newly diagnosed type 1 DM (T1DM) and compared to healthy controls.

Methods

Children with T1DM and healthy controls were included. The age, weight, height, body mass index (BMI), severity of acidosis, glucose, insulin, C-peptide, and diabetes-specific autoantibodies of children with newly diagnosed T1DM were collected. PGRN was measured in children with T1DM at admission, at first week of follow-up, and in healthy controls.

Results

A total of 49 children were included; 25 with T1DM [12 Female/13 Male (12F/13M)] and 24 healthy controls (10F/14M). There was no differences in age (11±3.9 years vs 12.1±3.1 years, p=0.269) and BMI standard deviation (SD) score (-0.11±1.49 SD vs. 0.10±0.82 SD, p=0.540) of children with T1DM and healthy controls. The mean basal PGRN level of children with newly diagnosed T1DM was higher than in controls (90.8±17.3 ng/mL vs. 30±11.5 ng/mL, p<0.001). In children with T1DM, mean basal PGRN at admission had declined significantly (58.4±16.9 ng/mL; p<0.001) in the first week after glycemic regulation was achieved but remained significantly higher than in controls (p<0.001).

Conclusion

These findings suggest that elevated PGRN levels in children with newly diagnosed T1DM may reflect either an acute inflammatory response to diabetic ketoacidosis or a persistent alteration in metabolic regulation, or both of these, highlighting the potential role of PGRN as a biomarker in the early course of T1DM.

Keywords: Diabetic ketoacidosis, pediatric, progranulin, PGRN, type 1 diabetes mellitus

Graphical Abstract

Read the full text

5 sections · 1 figure · 2 tables · PDF

Create your free account to read the full text.

  • Full text with figures and tables
  • PDF and supplementary files
  • Access on every Galenos journal
Get free access

Already have an account?

Sign in
or
Continue with Google

One Galenos account works on every Galenos journal site.

References

1

Zanocco-Marani T, Bateman A, Romano G, Valentinis B, He ZH, Baserga R. Biological activities and signaling pathways of the granulin/epithelin precursor. Cancer Res. 1999;59:5331-5340.

2

Baba T, Hoff HB 3rd, Nemoto H, Lee H, Orth J, Arai Y, Gerton GL. Acrogranin, an acrosomal cysteine-rich glycoprotein, is the precursor of the growth-modulating peptides, granulins, and epithelins, and is expressed in somatic as well as male germ cells. Mol Reprod Dev. 1993;34:233-243.

3

Zhou J, Gao G, Crabb JW, Serrero G. Purification of an autocrine growth factor homologous with mouse epithelin precursor from a highly tumorigenic cell line. J Biol Chem. 1993;268:10863-10869.

4

Tanimoto R, Lu KG, Xu SQ, Buraschi S, Belfiore A, Iozzo RV, Morrione A. Mechanisms of progranulin action and regulation in genitourinary cancers. Front Endocrinol (Lausanne). 2016;7:100.

5

He Z, Ong CH, Halper J, Bateman A. Progranulin is a mediator of the wound response. Nat Med. 2003;9:225-229. Epub 2003 Jan 13

6

He Z, Bateman A. Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J Mol Med (Berl). 2003;81:600-612. Epub 2003 Aug 19

7

Lan YJ, Sam NB, Cheng MH, Pan HF, Gao J. Progranulin as a potential therapeutic target in immune-mediated diseases. J Inflamm Res. 2021;14:6543-6556.

8

Nicoletto BB, Krolikowski TC, Crispim D, Canani LH. Serum and urinary progranulin in diabetic kidney disease. PLoS One. 2016;11:e0165177.

9

Albeltagy ES, Hammour AE, Albeltagy SA. Potential value of serum Progranulin as a biomarker for the presence and severity of micro vascular complications among Egyptian patients with type 2 diabetes mellitus. J Diabetes Metab Disord. 2019;18:217-228.

10

Pogonowska M, Poniatowski ŁA, Wawrzyniak A, Królikowska K, Kalicki B. The role of progranulin (PGRN) in the modulation of anti-inflammatory response in asthma. Cent Eur J Immunol. 2019;44:97-101. Epub 2019 Apr 15

11

Jian J, Konopka J, Liu C. Insights into the role of progranulin in immunity, infection, and inflammation. J Leukoc Biol. 2013;93:199-208. Epub 2012 Oct 22

12

Forbes JM, Thallas V, Thomas MC, Founds HW, Burns WC, Jerums G, Cooper ME. The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes. FASEB J. 2003;17:1762-1764. Epub 2003 Jul 18

13

Rohoma K, Souka M, Elsayed E, Mohamed S, Fathalla R. Study of serum progranulin level and its relation to microvascular complications in subjects with type 1 diabetes mellitus. Clin Diabetol. 2021;10:476-483.

14

Jakubek-Kipa K, Galiniak S, Mazur A. Progranulin and vaspin as potential novel markers in the etiology of type 1 diabetes in children. Medicina (Kaunas). 2024;60:1165.

15

Neyzi O, Bundak R, Gökçay G, Günöz H, Furman A, Darendeliler F, Baş F. Reference values for weight, height, head circumference, and body mass index in Turkish children. J Clin Res Pediatr Endocrinol. 2015;7:280-293.

16

Glaser N, Fritsch M, Priyambada L, Rewers A, Cherubini V, Estrada S, Wolfsdorf JI, Codner E. ISPAD Clinical Practice Consensus Guidelines 2022: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2022;23:835-856.

17

Wang F, Chen T, Sun L, Lv H, Li X, Shen J, Chen L, Chu Z, Hou M. Circulating PGRN levels are increased but not associated with insulin sensitivity or β-cell function in Chinese obese children. Dis Markers. 2018;2018:3729402.

18

Zhou M, Tang W, Fu Y, Xu X, Wang Z, Lu Y, Liu F, Yang X, Wei X, Zhang Y, Liu J, Geng X, Zhang C, Wan Q, Li N, Yi F. Progranulin protects against renal ischemia/reperfusion injury in mice. Kidney Int. 2015;87:918-929.

19

Schlatzer D, Maahs DM, Chance MR, Dazard JE, Li X, Hazlett F, Rewers M, Snell-Bergeon JK. Novel urinary protein biomarkers predicting the development of microalbuminuria and renal function decline in type 1 diabetes. Diabetes Care. 2012;35:549-555. Epub 2012 Jan 11

20

Tang W, Lu Y, Tian QY, Zhang Y, Guo FJ, Liu GY, Syed NM, Lai Y, Lin EA, Kong L, Su J, Yin F, Ding AH, Zanin-Zhorov A, Dustin ML, Tao J, Craft J, Yin Z, Feng JQ, Abramson SB, Yu XP, Liu CJ. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science. 2011;332:478-484. Epub 2011 Mar 10